Profil

Frere Pascale

See author's contact details
Main Referenced Co-authors
Beguin, Yves  (22)
Fillet, Georges  (19)
Baron, Frédéric  (16)
Baudoux, Etienne  (6)
Willems, Evelyne  (6)
Main Referenced Keywords
Humans (20); Middle Aged (16); Male (15); Female (14); Adult (11);
Main Referenced Disciplines
Hematology (22)
General & internal medicine (1)
Surgery (1)

Publications (total 24)

The most downloaded
565 downloads
Vanstraelen, G., Frere, P., Ngirabacu, M.-C., Willems, E., Fillet, G., & Beguin, Y. (2006). Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation. Experimental Hematology, 34 (3), 382-8. doi:10.1016/j.exphem.2005.11.013 https://hdl.handle.net/2268/6315

The most cited

42 citations (Scopus®)

Frere, P., Hermanne, J.-P., Debouge, M.-H., De Mol, P., Fillet, G., & Beguin, Y. (2004). Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplantation, 33 (7), 745-9. doi:10.1038/sj.bmt.1704414 https://hdl.handle.net/2268/9391

Dugauquier, C., Bataille, Y., Willems, E., Frere, P., De Prijck, B., Beguin, Y., & Baron, F. (2009). Toxoplasmore cérébrale compliquant une mini-allogreffe de cellules souches hématopoïétiques du sang périphérique. Revue Médicale de Liège, 64 (7-8), 366-369.
Peer reviewed

Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

De Pasqual, A., Deprez, M., Ghaye, B., Frere, P., Kaschten, B., Hayette, M.-P., Radermecker, M., Martin, D., & Canivet, J.-L. (2008). Mucormycose invasive du poumon et du rachis dorsal. Revue Médicale de Liège, 63, 702-706.
Peer reviewed

Vanstraelen, G., Baron, F., Willems, E., Bonnet, C., Hafraoui, K., Frere, P., Fillet, G., & Beguin, Y. (2006). Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. Experimental Hematology, 34 (7), 841-50. doi:10.1016/j.exphem.2006.04.012
Peer reviewed

Frere, P., Baron, F., Bonnet, C., Hafraoui, K., Pereira-Martins, M., Willems, E., Fillet, G., & Beguin, Y. (2006). Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplantation, 37 (4), 411-8. doi:10.1038/sj.bmt.1705255
Peer Reviewed verified by ORBi

Frere, P., Pereira-Martins, M., Fillet, G., & Beguin, Y. (2006). Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation. European Journal of Haematology, 76 (2), 102-8. doi:10.1111/j.1600-0609.2005.00569.x
Peer Reviewed verified by ORBi

Vanstraelen, G., Frere, P., Ngirabacu, M.-C., Willems, E., Fillet, G., & Beguin, Y. (2006). Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation. Experimental Hematology, 34 (3), 382-8. doi:10.1016/j.exphem.2005.11.013
Peer reviewed

Vanstraelen, G., Baron, F., Frere, P., Hafraoui, K., Fillet, G., & Beguin, Y. (2005). Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation. Haematologica, 90 (9), 1269-70.
Peer Reviewed verified by ORBi

Willems, E., Baron, F., Vanstraelen, G., Frere, P., Fillet, G., & Beguin, Y. (2005). Immunotherapie du cancer par minigreffe de cellules souches hematopoietiques. Revue Médicale Suisse, 1 (30), 1973-7.
Peer Reviewed verified by ORBi

Frere, P., Hermanne, J.-P., Debouge, M.-H., De Mol, P., Fillet, G., & Beguin, Y. (2004). Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplantation, 33 (7), 745-9. doi:10.1038/sj.bmt.1704414
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment. Clinical Cancer Research, 9 (15), 5566-72.
Peer Reviewed verified by ORBi

Baron, F., Frere, P., & Beguin, Y. (2003). Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment. Haematologica, 88 (6), 718-20.
Peer Reviewed verified by ORBi

Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Baudoux, E., Sautois, B., Fillet, G., & Beguin, Y. (2003). Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. Haematologica, 88 (4), 478-80.
Peer Reviewed verified by ORBi

Canivet, J.-L., Yans, T., Piret, S., Frere, P., & Beguin, Y. (2003). Barotrauma-induced tension pneumoperitoneum. Acta Anaesthesiologica Belgica, 54 (3), 233-6.
Peer Reviewed verified by ORBi

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion. British Journal of Haematology, 123 (1), 103-5. doi:10.1046/j.1365-2141.2003.04556.x
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Baudoux, E., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2003). Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update. Haematologica, 88 (7), 835-7.
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Herens, C., Fillet, G., & Beguin, Y. (2002). Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML. Haematologica, 87 (12), 43.
Peer Reviewed verified by ORBi

Frere, P., Hermanne, J.-P., Debouge, M.-H., Fillet, G., & Beguin, Y. (2002). Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation, 29 (7), 589-94. doi:10.1038/sj/bmt/1703413
Peer Reviewed verified by ORBi

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G., & Beguin, Y. (2002). Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. Journal of Hematotherapy and Stem Cell Research, 11 (2), 301-14. doi:10.1089/152581602753658484
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2001). Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571. Haematologica, 86 (9), 993-4.
Peer Reviewed verified by ORBi

Frere, P., Canivet, J.-L., Gennigens, C., Rebeix, J. P., Fillet, G., & Beguin, Y. (2000). Hyperammonemia after high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplantation, 26 (3), 343-5. doi:10.1038/sj.bmt.1702485
Peer Reviewed verified by ORBi

Franchimont, D., Frere, P., Lebrun, F., Fassotte, M. F., & D'Orio, V. (March 1996). Le cas clinique du mois. Syndrome de Moskowitz chez une patiente traitée par ticlopidine. Revue Médicale de Liège, 51 (3), 214-6.
Peer reviewed

Contact ORBi